This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (571)

Published on in Vol 6, No 6 (2017): June

Stroke Avoidance for Children in REpública Dominicana (SACRED): Protocol for a Prospective Study of Stroke Risk and Hydroxyurea Treatment in Sickle Cell Anemia

Stroke Avoidance for Children in REpública Dominicana (SACRED): Protocol for a Prospective Study of Stroke Risk and Hydroxyurea Treatment in Sickle Cell Anemia

Stroke Avoidance for Children in REpública Dominicana (SACRED): Protocol for a Prospective Study of Stroke Risk and Hydroxyurea Treatment in Sickle Cell Anemia

Authors of this article:

Neelum D Jeste1 Author Orcid Image ;   Luisanna M Sánchez2 Author Orcid Image ;   Gabriela S Urcuyo2 Author Orcid Image ;   Melissa E Bergés2 Author Orcid Image ;   Judy P Luden1 Author Orcid Image ;   Susan E Stuber1 Author Orcid Image ;   Teresa S Latham1 Author Orcid Image ;   Rafael Mena3 Author Orcid Image ;   Rosa M Nieves4 Author Orcid Image ;   Russell E Ware1 Author Orcid Image
Article Authors Cited by (6) Tweetations (3) Metrics

Journals

  1. Estcourt L, Kohli R, Hopewell S, Trivella M, Wang W. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease. Cochrane Database of Systematic Reviews 2020;2020(7) View
  2. Power-Hays A, Ware R. Effective use of hydroxyurea for sickle cell anemia in low-resource countries. Current Opinion in Hematology 2020;27(3):172 View
  3. Smart L, Hernandez A, Ware R. Sickle cell disease: Translating clinical care to low-resource countries through international research collaborations. Seminars in Hematology 2018;55(2):102 View
  4. Mandalaneni K, Venkatapathappa P, Koshy S, Walcott-Bedeau G, Singh V. Transcranial Doppler Ultrasonography-Related Research in the Caribbean Region. Cureus 2023 View
  5. Lugthart S, Ginete C, Kuona P, Brito M, Inusa B. An update review of new therapies in sickle cell disease: the prospects for drug combinations. Expert Opinion on Pharmacotherapy 2024;25(2):157 View
  6. Barak M, Hu C, Matthews A, Fortenberry Y. Current and Future Therapeutics for Treating Patients with Sickle Cell Disease. Cells 2024;13(10):848 View